Private Equity Portfolio Company
GliXogen Therapeutics
Ness Ziona
Israel
https://www.futurx.co.il/portfolio/glixogen-therapeutics
GliXogen Therapeutics is developing novel inhibitors of the transcription factor Gli1 to enhance remyelination in demyelination indication such as multiple sclerosis....
Private Equity Owner: OrbiMed Advisors
Acquisition Criteria
Investment Date:
Exit Date:
Status:
Add-on Acquisitions:
Industry (NAICS Code):
Testimonials
Become the next customer to share a success story about Private Equity Info's impact.
"Private Equity Info is critical to nearly every aspect of our role as an investment bank. We use it almost every day and the return on investment is clear."
Bob McCormack
"PEI is superior for our sales team. It cuts to the core. It’s the sweet spot in terms of what you’re paying and what you’re getting.”
